Creative Medical Technology Holdings Files Provisional Patent on Novel Type 1 Diabetes Immunotherapy Using Exosomes from MyeloCelz™ Platform
October 1st, 2021 | 🕒
https://www.ispeech.org PHOENIX, Oct. 1, 2021 /PRNewswire/ -- Creative Medical Technology Holdings Inc. (OTC – CELZ) announced today filing a new
Gloss